AZ SB1216

Limits total out-of-pocket costs for prescription insulin drugs to $35 per 30-day supply across all health insurance types (medical service corporations, health care services organizations, disability insurers, blanket disability insurers, and accountable health plans), regardless of insulin type or amount needed.

Applies the $35 cap to "prescription insulin drugs" defined as any prescription medication containing insulin prescribed by a health care professional to treat diabetes.

Allows insurers to continue imposing deductibles, coinsurance, and other cost-sharing measures for diabetes equipment and supplies, except for the $35 monthly insulin cap.

Amends sections 20-826, 20-1057, 20-1342, 20-1402, 20-1404, and 20-2325 of Arizona Revised Statutes to apply the insulin cost cap uniformly across different health insurance plan types.

Does not eliminate other cost-sharing mechanisms for insulin or related diabetes care; the cap applies only to the total monthly out-of-pocket expenses for covered prescription insulin drugs.